Impact Factor
3.50
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.11
1,146 total citations
h5-index
36
h5 depth signal
Cited share
62.3%
248 of 398
Total citations
1,146
Citation footprint
Metric signal
2.91
External metric anchor
Self-citation
13.2%
151 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
334
Italy
322
United Kingdom
227
Germany
190
China
188
Citing Fields of Research
Allergies
1,548
Immunology
274
Hematology
103
Nutrition & Dietetics
101
Virology
88
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,762
Articles tracked across the journal lifetime
Indexed publication set
398
248 cited publications
Last 12 months
289
24.1 publications/month
Open access share
42.9%
124 OA publications in the last year
Leading citing country
United States
334 citing publications
Leading citing field
Allergies
1,548 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v4n1,Feb. 1993-
v4n1,Feb. 1993-
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Issuing & Sponsoring Bodies
Contributor
European Society of Pediatric Allergy and Immunology
Broad Categories
Allergy and Immunology
Pediatrics
Allergies
MeSH Descriptors
Adolescent
Child
Hypersensitivity
Immune System Diseases
Infant
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1111/pai.70509
Open DOI
Peripheral effector‐memory CD4 + T cells reflect clinical symptom burden in pediatric allergic rhinitis
Background: Pediatric allergic rhinitis (AR) can substantially affect quality of life and school performance, yet conventional sensitization markers such as allergen‐specific immunoglobulin E (sIgE) do not consistently reflect symptom se...
03
DOI 10.1111/pai.70507
Open DOI
International survey of parental and patient perspectives on emerging adrenaline devices for community‐based management of anaphylaxis: An EAACI task force report
Introduction: Intranasal adrenaline has been approved in multiple countries for anaphylaxis treatment, based primarily on pharmacokinetic/pharmacodynamic comparisons to adrenaline autoinjectors (AAIs). Aim: To assess patient and caregive...
04
DOI 10.1111/pai.70525
Open DOI
PAI‐APAPARI Award 2026
05
06
07
DOI 10.1111/pai.70498
Open DOI
Early predictors of persistent childhood asthma and allergic rhinitis: A machine learning study using post‐hoc explainability
Background: Asthma and allergic rhinitis (AR) follow heterogeneous childhood trajectories, and reliable early prediction of persistence or remission remains challenging. We investigated whether machine learning models applied to early‐li...
08
DOI 10.1111/pai.70514
Open DOI
Intranasal corticosteroids in pediatric airway inflammation: From pharmacokinetics and evidence to optimized clinical practice
Intranasal corticosteroids (INS) are widely recommended as first‐line therapy for pediatric upper airway disorders due to their potent local anti‐inflammatory effects and favorable safety profile. This narrative review evaluates current ...
09
DOI 10.1111/pai.70522
Open DOI
Reply to Fatih Kaplan
10
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 1, no. 1 (AUG 1990)19931221 Notice not published Printed on acid-free paper